Business Description
Argent Biopharma Ltd
ISIN : AU0000326647
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | -0.48 | |||||
Debt-to-Equity | -0.2 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -22.26 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -69.5 | |||||
3-Year EBITDA Growth Rate | 61.6 | |||||
3-Year EPS without NRI Growth Rate | 56.7 | |||||
3-Year FCF Growth Rate | 63.6 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.16 | |||||
9-Day RSI | 34.54 | |||||
14-Day RSI | 40.62 | |||||
6-1 Month Momentum % | -9.87 | |||||
12-1 Month Momentum % | -47.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.23 | |||||
Quick Ratio | 0.15 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 613.82 | |||||
Days Sales Outstanding | 66.13 | |||||
Days Payable | 994.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -169.3 | |||||
Shareholder Yield % | -75.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.57 | |||||
Operating Margin % | -1083.01 | |||||
Net Margin % | -1082.77 | |||||
FCF Margin % | -889.56 | |||||
ROA % | -138.01 | |||||
ROIC % | -99.46 | |||||
3-Year ROIIC % | 346.03 | |||||
ROC (Joel Greenblatt) % | -245.79 | |||||
ROCE % | -27232.98 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.57 | |||||
EV-to-EBIT | -0.67 | |||||
EV-to-EBITDA | -0.71 | |||||
EV-to-Forward-EBITDA | -7.82 | |||||
EV-to-Revenue | 7.09 | |||||
EV-to-Forward-Revenue | 1.86 | |||||
EV-to-FCF | -0.9 | |||||
Earnings Yield (Greenblatt) % | -149.21 | |||||
FCF Yield % | -82.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Argent Biopharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.996 | ||
EPS (TTM) (€) | -0.33 | ||
Beta | -0.31 | ||
Volatility % | 104.37 | ||
14-Day RSI | 40.62 | ||
14-Day ATR (€) | 0.018564 | ||
20-Day SMA (€) | 0.25595 | ||
12-1 Month Momentum % | -47.5 | ||
52-Week Range (€) | 0.151 - 0.6 | ||
Shares Outstanding (Mil) | 53.61 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Argent Biopharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Argent Biopharma Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Argent Biopharma Ltd Frequently Asked Questions
What is Argent Biopharma Ltd(STU:H5O0)'s stock price today?
When is next earnings date of Argent Biopharma Ltd(STU:H5O0)?
Does Argent Biopharma Ltd(STU:H5O0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |